Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study

Journal of Endocrinological Investigation

Volumn 34, Issue 10, 2011, Pages 757-763

  Wehr, E ^a   Pieber, T R ^a   Obermayer Pietsch, B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Fertility; Glucose metabolism; Intervention; PCOS; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; ANDROGEN; C PEPTIDE; C REACTIVE PROTEIN; COLECALCIFEROL; ESTRADIOL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEOVIT D3; TESTOSTERONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD CHEMISTRY; BLOOD EXAMINATION; BLOOD SAMPLING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEMALE; FEMALE FERTILITY; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; MENSTRUATION DISORDER; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; SCREENING; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLOOD GLUCOSE; C-PEPTIDE; CHOLECALCIFEROL; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; MENSTRUATION; MENSTRUATION DISTURBANCES; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 84856855846     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7748     Document Type: Article

References (44)

1. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85: 2434-8.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84: 4006-11. (Pubitemid 30644187)
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18: 774-800. (Pubitemid 28009567)
4. Wehr E, Möller R, Horejsi R, et al. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wien Klin Wochenschr 2009, 121: 262-9.
5. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005, 352: 1223-36.
6. Hahn S, Haselhorst U, Tan S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006, 114: 577-83. (Pubitemid 46087264)
7. Wehr E, Pilz S, Schweighofer N, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009, 161: 575-82.
8. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357: 266-81.
9. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92: 2017-29. (Pubitemid 46997093)
10. Freundlich M, Quiroz Y, Zhang Z, et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008, 74: 1394-402.
11. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79: 820-5. (Pubitemid 41103882)
12. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001, 24: 1496.
13. Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010, 93: 1208-14.
14. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008, 47: 87-91.
15. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004, 89: 1196-9. (Pubitemid 38368412)
16. Heaney RP, Horst RL, Cullen DM, Armas LA. Vitamin D3 distribution and status in the body. J Am Coll Nutr 2009, 28: 252-6.
17. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41-7.
18. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004, 59: 141-54. (Pubitemid 38140845)
19. Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008, 93: 3450-5.
20. Whiting SJ, Calvo MS. Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults? Mol Nutr Food Res 2010, 54: 1077-84.
21. Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89: 1321-7.
22. Pilz S, Dobnig H, Winklhofer-Roob B, et al. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev 2008, 17: 1228-33.
23. Pilz S, März W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93: 3927-35.
24. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167: 1730-7. (Pubitemid 47403059)
25. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of non-vertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169: 551-61.
26. Zittermann A, Gummert JF, Börgermann J. Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care 2009, 12: 634-9.
27. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30: 980-6. (Pubitemid 46556596)
28. Hsia J, Heiss G, Ren H, et al Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115: 846-54. (Pubitemid 46294725)
29. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009, 92: 1053-8.
30. Selimoglu H, Duran C, Kiyici S, et al. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 2010, 33: 234-8.
31. Lacour B, Basile C, Drüeke T, Funck-Brentano JL. Parathyroid function and lipid metabolism in the rat. Miner Electrolyte Metab 1982, 7: 157-65. (Pubitemid 12118779)
32. Rajpathak SN, Xue X, Wassertheil-Smoller S, et al. Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative. Am J Clin Nutr 2010, 91: 894-9.
33. Ozkan S, Jindal S, Greenseid K, et al. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril 2010, 94: 1314-9.
34. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999, 64: 430-5. (Pubitemid 29340525)
35. Yildizhan R, Kurdoglu M, Adali E, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009, 280: 559-63.
36. Knight JA, Wong J, Blackmore KM, Raboud JM, Vieth R. Vitamin D association with estradiol and progesterone in young women. Cancer Causes Control 2010, 21: 479-83.
37. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007, 16: 422-9. (Pubitemid 46548644)
38. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993, 15: 17-35. (Pubitemid 23269068)
39. Du H, Daftary GS, Lalwani SI, Taylor HS. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol 2005, 19: 2222-33. (Pubitemid 41252818)
40. Halloran BP, DeLuca HF. Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr 1980, 110: 1573-80. (Pubitemid 11192819)
41. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997, 16: 391-6. (Pubitemid 27323308)
42. Kovacs CS, Woodland ML, Fudge NJ, Friel JK. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. Am J Physiol Endocrinol Metab 2005, 289: E133-44. (Pubitemid 40874944)
43. De Felici M, Dolci S, Siracusa G. An increase of intracellular free Ca2+ is essential for spontaneous meiotic resumption by mouse oocytes. J Exp Zool 1991, 260: 401-5.
44. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80: 1678-88S.